SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-23-020000
Filing Date
2023-12-22
Accepted
2023-12-22 17:00:37
Documents
85
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-K otlk-20230930x10k.htm   iXBRL 10-K 2227082
2 EX-4.1 otlk-20230930xex4d1.htm EX-4.1 38469
3 EX-10.26 otlk-20230930xex10d26.htm EX-10.26 42233
4 EX-10.30 otlk-20230930xex10d30.htm EX-10.30 26926
5 EX-21.1 otlk-20230930xex21d1.htm EX-21.1 5304
6 EX-23.1 otlk-20230930xex23d1.htm EX-23.1 2859
7 EX-31.1 otlk-20230930xex31d1.htm EX-31.1 13545
8 EX-31.2 otlk-20230930xex31d2.htm EX-31.2 13963
9 EX-32.1 otlk-20230930xex32d1.htm EX-32.1 12778
10 EX-97 otlk-20230930xex97.htm EX-97 42627
11 GRAPHIC otlk-20230930x10k006.jpg GRAPHIC 26358
12 GRAPHIC otlk-20230930x10k007.jpg GRAPHIC 49932
13 GRAPHIC otlk-20230930x10k008.jpg GRAPHIC 51929
  Complete submission text file 0001558370-23-020000.txt   9348356

Data Files

Seq Description Document Type Size
14 EX-101.SCH otlk-20230930.xsd EX-101.SCH 50107
15 EX-101.CAL otlk-20230930_cal.xml EX-101.CAL 52686
16 EX-101.DEF otlk-20230930_def.xml EX-101.DEF 261330
17 EX-101.LAB otlk-20230930_lab.xml EX-101.LAB 451181
18 EX-101.PRE otlk-20230930_pre.xml EX-101.PRE 410971
79 EXTRACTED XBRL INSTANCE DOCUMENT otlk-20230930x10k_htm.xml XML 1483135
Mailing Address 485 ROUTE 1 SOUTH BUILDING F, SUITE 320 ISELIN NJ 08830
Business Address 485 ROUTE 1 SOUTH BUILDING F, SUITE 320 ISELIN NJ 08830 6096193990
Outlook Therapeutics, Inc. (Filer) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 001-37759 | Film No.: 231510634
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)